(Press-News.org) Annals of Internal Medicine Tip Sheet
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. Acupuncture may offer limited relief to patients with chronic hives
Abstract: https://www.acpjournals.org/doi/10.7326/M23-1043
Editorial: https://www.acpjournals.org/doi/10.7326/M23-2713
URL goes live when the embargo lifts
A randomized controlled trial that included more than 300 people diagnosed with chronic spontaneous urticaria (CSU), or hives, found that acupuncture may offer limited relief from the condition, but clinical significance of this finding was unclear. The study is published in Annals of Internal Medicine.
CSU is the most common form of chronic hives and is characterized by recurrent itching, skin lesions, or swelling lasting more than 6 weeks in the absence of specific triggering factors. More than 90 percent of patients with CSU require urgent medical treatment to relieve itching; therefore, the management of itching is one of the main goals in the treatment of CSU.
Researchers from Chengdu University of Traditional Chinese Medicine randomly assigned 330 persons diagnosed with CSU to receive either 4 weeks of acupuncture, 4 weeks of sham acupuncture, or a waitlist (control) and then followed the patients for 4 weeks after treatment to investigate whether acupuncture leads to improvement of CSU synptoms. Changes in symptoms were measured using the Weekly Urticaria Activity Score (UAS7). Patients in the acupuncture group reported improved UAS7, more than sham acupuncture or waitlist control. However, the differences between intervention and control did not meet the minimal clinical difference (MCID) threshold, so the clinical significance of the observed reductions in itch severity scores is uncertain. The rate of adverse events was highest in the acupuncture group, but events were mild and transient.
An accompanying editorial by Mike Cummings of the British Medical Acupuncture Society highlights that these trial results are interesting because they describe the efficacy of acupuncture in a condition that is not characterized by pain. While clinical significance of the findings was not clear, the author suggests that clinicians should stay open to the potential for adjunctive use of acupuncture to influence outcomes, even in more serious medical conditions. The editorial suggests that acupuncture is often overlooked as a therapy because it lacks the commercial backing of other modern interventions.
Media contacts: For an embargoed PDF, please contact Angela Collom at acollom@acponline.org. To speak with the corresponding author, Ying Li, MD, PhD, please contact liying@cdutcm.edu.cn.
----------------------------
Also in this issue:
Impact of Clinical Demands on the Educational Mission in Hospital Medicine at 17 Academic Medical Centers
Academia and the Profession
Vishruti Patel, MD; Angela Keniston, PhD, MSPH; Lauren McBeth, BA; Sagarika Arogyaswamy, MD; Catherine Callister, MD; Khooshbu Dayton, MD; Neelam Mistry, MD; Sarah Mann, MA; and Marisha Burden, MD, MBA
Abstract: https://www.acpjournals.org/doi/10.7326/M23-1497
Breast Cancer Screening and Prevention
In the Clinic
Amy H. Farkas, MD, MS; Ann B. Nattinger, MD, MPH
Abstract: https://www.acpjournals.org/doi/10.7326/AITC202311210
END
Acupuncture may offer limited relief to patients with chronic hives
2023-11-13
ELSE PRESS RELEASES FROM THIS DATE:
Virologic rebound observed in 20% of patients treated with nirmatrelvir-ritonavir
2023-11-13
Embargoed for release until 5:00 p.m. ET on Monday 13 November 2023
Annals of Internal Medicine Tip Sheet
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf ...
One in five patients experience rebound COVID after taking Paxlovid, new study finds
2023-11-13
A new study by investigators from Mass General Brigham found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and shedding of live and potentially contagious virus following an initial recovery and negative test—a phenomenon known as virologic rebound. By contrast, people not taking Paxlovid only experienced rebound about 2 percent of the time. Results are published in Annals of Internal Medicine.
“We conducted this study to address lingering questions about Paxlovid and virologic rebound in COVID-19 treatment,” said corresponding ...
Scientists discover key to a potential natural cancer treatment’s potency
2023-11-13
JUPITER, Fla. — Slumbering among thousands of bacterial strains in a collection of natural specimens at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, several fragile vials held something unexpected, and possibly very useful.
Writing in the journal Nature Chemical Biology, a team led by chemist Ben Shen, Ph.D., described discovery of two new enzymes, ones with uniquely useful properties that could help in the fight against human diseases including cancer. The discovery, published ...
Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types
2023-11-13
New York, NY (November 13, 2023)—Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed “prognostic modules,” that significantly influence the progression of 32 different types of cancer. The study, published in Genome Research, serves as a comprehensive resource and lays the foundation for the development of next-generation cancer treatments and diagnostic markers.
Despite significant progress in cancer research, understanding the disease's genetic intricacies ...
Ammonia fuel offers great benefits but demands careful action
2023-11-13
Ammonia, a main component of many fertilizers, could play a key role in a carbon-free fuel system as a convenient way to transport and store clean hydrogen. The chemical, made of hydrogen and nitrogen (NH3), can also itself be burned as a zero-carbon fuel. However, new research led by Princeton University illustrates that even though it may not be a source of carbon pollution, ammonia’s widespread use in the energy sector could pose a grave risk to the nitrogen cycle and climate without proper engineering precautions.
Publishing their findings in PNAS, the interdisciplinary team of 12 researchers found that a well-engineered ammonia economy could help the world achieve ...
Low-intensity fires reduce wildfire risk by 60%, study finds
2023-11-13
November 13, 2023-- There is no longer any question of how to prevent high-intensity, often catastrophic, wildfires that have become increasingly frequent across the Western U.S., according to a new study by researchers at Columbia University Mailman School of Public Health and Stanford University. The analysis reveals that low-intensity burning, such as controlled or prescribed fires, managed wildfires, and tribal cultural burning, can dramatically reduce the risk of devastating fires for years at a time. The findings are some of the first to rigorously quantify the value of low-intensity fire and be released while Congress is reassessing ...
Astrophysicist uses NSF funding to grow the number of deaf, hard-of-hearing, and Hispanic researchers
2023-11-13
Astrophysicist Jason Nordhaus is breaking cultural and disciplinary boundaries by helping to grow the number of deaf, hard-of-hearing, and Hispanic researchers. And, in doing so, he is enabling these future scientists to drive discoveries in one of his areas of expertise—neutron star astrophysics.
Nordhaus, an associate professor of physics at Rochester Institute of Technology’s National Technical Institute for the Deaf, has earned a National Science Foundation grant that connects NTID with Texas Tech University, a Hispanic Serving Institution. Through a series of unique summer research exchanges ...
A ‘fish cartel’ for Africa could benefit the countries, and their seas
2023-11-13
Banding together to sell fishing rights could generate economic benefits for African countries, which receive far less from access to their fisheries on the global market than other countries do from theirs. By joining forces, UC Santa Barbara researchers say in a paper published in the journal Nature Communications, African fisheries would not just secure more competitive access fees, they could also protect their seas’ biodiversity.
“If African countries created a ‘fish cartel’ to sell fishing rights to foreign vessels, they could increase their fish biomass by 16% and make 23% more in profits,” ...
Absorbable scaffold outperforms angioplasty for lower-leg artery disease
2023-11-13
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, which has been the standard treatment, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Angioplasty involves the widening of a narrowed artery with a small, balloon-like mechanism. A resorbable scaffold is a stent-like structure that props the artery open but is biodegradable and dissolves within a few years, avoiding some of the potential complications of a permanent ...
New compound outperforms pain drug by indirectly targeting calcium channels
2023-11-13
A compound—one of 27 million screened in a library of potential new drugs—reversed four types of chronic pain in animal studies, according to new research led by NYU College of Dentistry’s Pain Research Center and published in the Proceedings of the National Academy of Sciences (PNAS).
The small molecule, which binds to an inner region of a calcium channel to indirectly regulate it, outperformed gabapentin without troublesome side effects, providing a promising candidate for treating pain.
Calcium channels play a central role in pain signaling, in part through the release of neurotransmitters such as glutamate and GABA— “the ...